Supplement Industry Self-Regulation At Center Stage As Oversight Dims Under Trump
This article was originally published in The Rose Sheet
Executive Summary
The Trump administration's easing of industries' regulatory burdens leaves an oversight void some states are ready to fill, while also giving the supplement industry an opportunity to show self-regulation makes a difference in the quality of products available to US consumers, say food and drug law attorneys.
You may also be interested in...
FTC Chair Nominee Links Ad Claims Enforcement To Consumers' Loss
President Trump nominates as FTC chair Joseph Simons, an antitrust attorney who led its Bureau of Competition under former President Bush. Advertising law attorneys say Simons sees whether consumers incurred economic injury to be central to enforcement on false advertising complaints.
Another Court Ruling Rejects RCT Standard For Supplement Claims
Two years after Bayer prevailed against FTC's demand for RCTs to substantiate claims for its Phillips Colon Health probiotic, a judge dismisses a class action complaint targeting the product, saying the plaintiffs did not support their argument and their expert expected supplements to be evaluated as drugs.
Supplement OWL Registry Counts On Peer Pressure To Spur Use
CRN-organized Supplement OWL launches with nearly 2,600 labels included and adds almost 500 more in its first week, though a much larger total is needed to offer drug store chains and other retailers access a broader perspective of products available in the US.